Lawmakers have yet to settle on language to reauthorize multiple FDA pediatric provisions that expire this September in the lead-up to House and Senate markup sessions this week.
Two device pediatric provisions need to be reauthorized this year to continue: a profit allowance for products that are approved via humanitarian device exemption and include a pediatric indication, and...